SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Arterial Remodeling Technologies Receives Regulatory Approval to Begin First-In-Man "ARTDIVA" Clinical Trial With its Next-generation Bioresorbable Stent